Acibadem Maslak Hospital in Turkey introduces next generation cancer care with MRIdian MR Image-guided radiation therapy
MR Linac is the newest technology that combined MRI and Linac for the first time in the world and Acibadem Maslak Hospital in Istanbul in Turkey has begun treating patients with it.
With this technology, radiation oncologist can treat the patient as a surgeon, because this device enables the physicians to see tumour precisely, even in soft tissues.
Acıbadem Maslak Hospital is the ninth MR Linac center in the world. MRIdian, MRI-guided radiotherapy, presents the state-of-the-art radiotherapy device to cancer patients. On table and continuous soft tissue imaging enables plan adaptation to reshape radiation doses based on the anatomical changes which occur from one day of treatment to the next. Using a novel streaming video perspective, the technology also allows oncologists to visualize and automatically control beam delivery based on the real-time position of the tumor and surrounding organs.
We are pleased to have commenced Turkey’s first MRI-guided radiation therapy program and believe it offers cancer patients in Turkey a number of distinct benefits over traditional radiation therapy,” said Prof. Enis Ozyar, M.D., the Chief of Acibadem Mehmet Ali Aydınlar University, School of Medicine, Department of Radiation Oncology.
“Most importantly, MRIdian allows for clinical improvements in visualization and precision daily plan adaptation, and it provides us with the tools to deliver higher and potentially more effective radiation doses.”
Turkey is currently one of the leading countries in health tourism due to the country’s advanced diagnostic and treatment services offered.
